Topics

Centrient Accuses India’s Dalas Of Amoxicillin Patent Infringement

01:31 EDT 2 May 2019 | SCRIP

Centrient Pharmaceuticals, which makes “sustainable antibiotics,” has filed an Indian lawsuit in the Delhi High Court against Dalas Biotech accusing...

      

Related Stories

 

Original Article: Centrient Accuses India’s Dalas Of Amoxicillin Patent Infringement

NEXT ARTICLE

More From BioPortfolio on "Centrient Accuses India’s Dalas Of Amoxicillin Patent Infringement"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...